Reports of Biochemistry
and Molecular Biology
Thu, Jul 3, 2025
[Archive]
Vol.13 No.4 Jan
Back to the articles list |
Back to browse issues page
Zahra Arab Sadeghabadi 
, Nasrin Ziamajidi , Roghayeh Abbasalipourkabir , Zohreh Khajehahmadi , Sina Mohagheghi , Heidar Tayebinia , Roohollah Mohseni *
, Nasrin Ziamajidi , Roghayeh Abbasalipourkabir , Zohreh Khajehahmadi , Sina Mohagheghi , Heidar Tayebinia , Roohollah Mohseni *
Clinical Biochemistry Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Abstract: (52 Views)
Background: The transforming growth factor beta1 (TGF-β1) signaling pathway plays a critical role in the pathogenesis of Type 2 diabetes mellitus (T2DM). Modulating this pathway may offer therapeutic benefits for managing T2DM. Chicoric acid (CA), a polyphenolic compound with reported anti-diabetic properties, has shown potential in metabolic regulation; however, its precise molecular mechanisms remain unclear. This study aimed to investigate the effects of palmitate and CA on the TGF-β1 signaling pathway in peripheral blood mononuclear cells (PBMCs) from newly diagnosed T2DM patients and healthy controls.
Methods: A total of 40 participants, including 20 newly diagnosed T2DM patients and 20 age-matched healthy individuals (40–60 years), were enrolled in this study. Peripheral blood mononuclear cells (PBMCs) were isolated and treated with palmitate and CA. The expression of TGF-β1 mRNA was analyzed using quantitative real-time polymerase chain reaction (qRT-PCR). Protein levels of Smad2/3 and phosphorylated Smad2/3 (p-Smad2/3) were assessed via western blot analysis.
Results: Palmitate stimulation significantly upregulated TGF-β1 gene expression and increased p-Smad2/3 protein levels in PBMCs. However, CA treatment effectively attenuated these palmitate-induced elevations in TGF-β1 expression and p-Smad2/3 protein levels. Additionally, a positive correlation was observed between TGF-β1 expression and p-Smad2/3 protein levels.
Conclusions: These findings suggest that CA may act as an inhibitor of the TGF-β1 signaling pathway, potentially contributing to T2DM management by downregulating TGF-β1/Smad signaling. Further studies are warranted to explore its therapeutic potential in diabetes treatment.
Methods: A total of 40 participants, including 20 newly diagnosed T2DM patients and 20 age-matched healthy individuals (40–60 years), were enrolled in this study. Peripheral blood mononuclear cells (PBMCs) were isolated and treated with palmitate and CA. The expression of TGF-β1 mRNA was analyzed using quantitative real-time polymerase chain reaction (qRT-PCR). Protein levels of Smad2/3 and phosphorylated Smad2/3 (p-Smad2/3) were assessed via western blot analysis.
Results: Palmitate stimulation significantly upregulated TGF-β1 gene expression and increased p-Smad2/3 protein levels in PBMCs. However, CA treatment effectively attenuated these palmitate-induced elevations in TGF-β1 expression and p-Smad2/3 protein levels. Additionally, a positive correlation was observed between TGF-β1 expression and p-Smad2/3 protein levels.
Conclusions: These findings suggest that CA may act as an inhibitor of the TGF-β1 signaling pathway, potentially contributing to T2DM management by downregulating TGF-β1/Smad signaling. Further studies are warranted to explore its therapeutic potential in diabetes treatment.
Keywords: Chicoric acid, Palmitate, Smad signaling, Transforming growth factor-beta 1, Type 2 diabetes mellitus.
Type of Article: Original Article |
Subject:
Biochemistry
Received: 2025/02/9 | Accepted: 2025/05/25
Received: 2025/02/9 | Accepted: 2025/05/25
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
